In the treatment of advanced hormone-resistant prostate cancer, the aim is an improvement in quality of life since treatment strategies are merely palliative and life cannot be prolonged. Therapy is based on medical pain relief for different aspects of pain without seriously affecting activity and quality of life. With respect to therapy of chronic pain, Germany can be regarded as a developing country. It is definitely in the interest of urological cancer patients that this situation will be finished.  
